Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Heaphy

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor SurvivalJoo Young Kim, Jacqueline A Brosnan-Cashman, Soyeon An, et al.
Nature Reviews. Urology|November 1, 2023
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancerJoakin O Mori, Isra Elhussin, W Nathaniel Brennen, et al.
Blood Advances|April 23, 2026
PGC-1α Agonism via Oral Administration of ZLN005 Induces Fetal Hemoglobin and is Anti-Sickling in Sickle MiceHajar Benmhammed, Yanan Sun, Salam AlAbdullatif, et al.
The American Journal of Pathology|October 29, 2022
Genomic Characterization of Prostatic Basal Cell CarcinomaJin-Yih Low, Minjeong Ko, Brian Hanratty, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 21, 2015
Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal CellsCorinne E Joshu, Sarah B Peskoe, Christopher M Heaphy, et al.
Molecular Cancer Research : MCR|October 16, 2019
Functional Loss of <i>ATRX</i> and <i>TERC</i> Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer CellsMindy K Graham, Jiyoung Kim, Joseph Da, et al.
The Journal of Clinical Investigation|October 19, 2013
Tracking the clonal origin of lethal prostate cancerMichael C Haffner, Timothy Mosbruger, David M Esopi, et al.
Endocrine Pathology|February 28, 2020
Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic InsulinomasWenzel M Hackeng, Willemien Schelhaas, Folkert H M Morsink, et al.
Acta Neuropathologica Communications|August 30, 2019
Telomere alterations in neurofibromatosis type 1-associated solid tumorsFausto J Rodriguez, Mindy K Graham, Jacqueline A Brosnan-Cashman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2012
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumorsRoeland F de Wilde, Christopher M Heaphy, Anirban Maitra, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor SurvivalJoo Young Kim, Jacqueline A Brosnan-Cashman, Soyeon An, et al.
Nature Reviews. Urology|November 1, 2023
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancerJoakin O Mori, Isra Elhussin, W Nathaniel Brennen, et al.
Blood Advances|April 23, 2026
PGC-1α Agonism via Oral Administration of ZLN005 Induces Fetal Hemoglobin and is Anti-Sickling in Sickle MiceHajar Benmhammed, Yanan Sun, Salam AlAbdullatif, et al.
The American Journal of Pathology|October 29, 2022
Genomic Characterization of Prostatic Basal Cell CarcinomaJin-Yih Low, Minjeong Ko, Brian Hanratty, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 21, 2015
Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal CellsCorinne E Joshu, Sarah B Peskoe, Christopher M Heaphy, et al.
Molecular Cancer Research : MCR|October 16, 2019
Functional Loss of <i>ATRX</i> and <i>TERC</i> Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer CellsMindy K Graham, Jiyoung Kim, Joseph Da, et al.
The Journal of Clinical Investigation|October 19, 2013
Tracking the clonal origin of lethal prostate cancerMichael C Haffner, Timothy Mosbruger, David M Esopi, et al.
Endocrine Pathology|February 28, 2020
Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic InsulinomasWenzel M Hackeng, Willemien Schelhaas, Folkert H M Morsink, et al.
Acta Neuropathologica Communications|August 30, 2019
Telomere alterations in neurofibromatosis type 1-associated solid tumorsFausto J Rodriguez, Mindy K Graham, Jacqueline A Brosnan-Cashman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2012
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumorsRoeland F de Wilde, Christopher M Heaphy, Anirban Maitra, et al.
Pageof 12